{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:30:46Z","timestamp":1790400646299,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,18]]},"DOI":"10.7759\/cureus.31662","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T08:00:00Z","timestamp":1668844800000},"source":"Crossref","is-referenced-by-count":5,"title":["Case Report: Effectiveness of Low-Dose Ketamine Infusion in Opioid Refractory Cancer Pain"],"prefix":"10.7759","author":[{"given":"Tuheen  S","family":"Nath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2015.12.340","article-title":"Update on prevalence of pain in patients with cancer: systematic review and meta-analysis","volume":"51","author":"van den Beuken-van Everdingen MH","year":"2016","unstructured":"van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016, 51:1070-1090.e9. 10.1016\/j.jpainsymman.2015.12.340","journal-title":"J Pain Symptom Manage"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/15360288.2016.1231732","article-title":"Successful treatment of opioid-refractory cancer pain with short-course, low-dose ketamine","volume":"30","author":"Waldfogel JM","year":"2016","unstructured":"Waldfogel JM, Nesbit S, Cohen SP, Dy SM. Successful treatment of opioid-refractory cancer pain with short-course, low-dose ketamine. J Pain Palliat Care Pharmacother. 2016, 30:294-7. 10.1080\/15360288.2016.1231732","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/15360288.2014.938881","article-title":"Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain","volume":"28","author":"Amin P","year":"2014","unstructured":"Amin P, Roeland E, Atayee R. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain. J Pain Palliat Care Pharmacother. 2014, 28:233-42. 10.3109\/15360288.2014.938881","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11040510","article-title":"Cancer pain assessment and classification","volume":"11","author":"Caraceni A","year":"2019","unstructured":"Caraceni A, Shkodra M. Cancer pain assessment and classification. Cancers (Basel). 2019, 11:10.3390\/cancers11040510","journal-title":"Cancers (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-019-00660-0","article-title":"Opioid-induced tolerance and hyperalgesia","volume":"33","author":"Mercadante S","year":"2019","unstructured":"Mercadante S, Arcuri E, Santoni A. Opioid-induced tolerance and hyperalgesia. CNS Drugs. 2019, 33:943-55. 10.1007\/s40263-019-00660-0","journal-title":"CNS Drugs"},{"key":"ref6","article-title":"A comprehensive review of opioid-induced hyperalgesia","volume":"14","author":"Lee M","year":"2011","unstructured":"Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011, 14:145-61.","journal-title":"Pain Physician"},{"key":"ref7","article-title":"Neurophysiology of opioid poorly responsive pain","volume":"21","author":"Dickenson AH","year":"1994","unstructured":"Dickenson AH. Neurophysiology of opioid poorly responsive pain. Cancer Surv. 1994, 21:5-16.","journal-title":"Cancer Surv"},{"key":"ref8","article-title":"The association of neuropathic pain, morphine tolerance and dependence, and the translocation of protein kinase C","volume":"147","author":"Mayer DJ","year":"1995","unstructured":"Mayer DJ, Mao J, Price DD. The association of neuropathic pain, morphine tolerance and dependence, and the translocation of protein kinase C. NIDA Res Monogr. 1995, 147:269-98.","journal-title":"NIDA Res Monogr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003351.pub3","article-title":"Ketamine as an adjuvant to opioids for cancer pain","volume":"6","author":"Bell RF","year":"2017","unstructured":"Bell RF, Eccleston C, Kalso EA. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev. 2017, 6:CD003351. 10.1002\/14651858.CD003351.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","article-title":"Controlling cancer pain with pharmacotherapy","volume":"107","author":"Pharo GH","year":"2007","unstructured":"Pharo GH, Zhou L. Controlling cancer pain with pharmacotherapy. J Am Osteopath Assoc. 2007, 107:ES22-32.","journal-title":"J Am Osteopath Assoc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/TME.0000000000000244","article-title":"The use of ketamine as an adjunct to treating opioid refractory cancer-related pain in the emergency department","volume":"41","author":"Brockett-Walker C","year":"2019","unstructured":"Brockett-Walker C. The use of ketamine as an adjunct to treating opioid refractory cancer-related pain in the emergency department. Adv Emerg Nurs J. 2019, 41:101-6. 10.1097\/TME.0000000000000244","journal-title":"Adv Emerg Nurs J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0885-3924(01)00340-2","article-title":"\"Burst\" ketamine for refractory cancer pain: an open-label audit of 39 patients","volume":"22","author":"Jackson K","year":"2001","unstructured":"Jackson K, Ashby M, Martin P, Pisasale M, Brumley D, Hayes B. \"Burst\" ketamine for refractory cancer pain: an open-label audit of 39 patients. J Pain Symptom Manage. 2001, 22:834-42. 10.1016\/s0885-3924(01)00340-2","journal-title":"J Pain Symptom Manage"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2017.0551","article-title":"Case report: ketamine for pain and depression in advanced cancer","volume":"21","author":"Sexton J","year":"2018","unstructured":"Sexton J, Atayee RS, Bruner HC. Case report: ketamine for pain and depression in advanced cancer. J Palliat Med. 2018, 21:1670-3. 10.1089\/jpm.2017.0551","journal-title":"J Palliat Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2008.9828","article-title":"Intravenous ketamine \"burst\" for refractory depression in a patient with advanced cancer","volume":"11","author":"Stefanczyk-Sapieha L","year":"2008","unstructured":"Stefanczyk-Sapieha L, Oneschuk D, Demas M. Intravenous ketamine \"burst\" for refractory depression in a patient with advanced cancer. J Palliat Med. 2008, 11:1268-71. 10.1089\/jpm.2008.9828","journal-title":"J Palliat Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/101153-case-report-effectiveness-of-low-dose-ketamine-infusion-in-opioid-refractory-cancer-pain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:58Z","timestamp":1707508198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/101153-case-report-effectiveness-of-low-dose-ketamine-infusion-in-opioid-refractory-cancer-pain"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.31662","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,18]]}}}